IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 121 - 140 of 1097 stories.
December 12, 2013
ScinoPharm (Tainan, Taiwan) says that it has completed the construction of a new facility at Changshu, China, and the new site includes a multipurpose active pharmaceutical ingredient...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/ScinoPharm-opens-API-plant-in-Changshu-plans-to-expand-site_57300.html
December 10, 2013
Celon Laboratories (Hyderabad, India) said on Monday that it has entered into an agreement with Aurobindo Pharma (Hyderabad) to form a joint venture to develop, manufacture, and sell...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Aurobindo-and-Celon-Laboratories-form-generics-JV-to-cater-US-and-Europe_57238.html
December 10, 2013
The Excipact Association, a project of the IPEC Federation (Brussels), says it has signed an agreement with DQS (Frankfurt), an internationally recognized certification body, for the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Excipact-signs-deal-with-DQS-for-audits-of-pharmaceutical-excipient-suppliers_57228.html
December 10, 2013
PCI Synthesis (Newburyport, MA), a manufacturer of new chemical entities, generic active pharmaceutical ingredients (APIs), complex pharmaceutical intermediates, and other specialty...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PCI-Synthesis-Increased-regulatory-scrutiny-wage-inflations-in-India-and-China-to-impact-industry-in-2014_57224.html
December 10, 2013
PCI Synthesis: Increased regulatory scrutiny, wage inflation in India and China, to impact industry in 2014 PCI Synthesis (Newburyport, MA), a manufacturer of new chemical entities...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-10-December-2013_57229.html
December 9, 2013
Nuevolution (Copenhagen, Denmark), a small molecule lead discovery company, says it has appointed Tom Berkien as chief business officer, effective 1 January. Berkien will lead...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Nuevolution-appoints-Berkien-as-chief-business-officer_57187.html
December 4, 2013
Cambridge Major Laboratories (CML; Germantown, WI), a producer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs); and AAIPharma Services (Wilmington, NC), a...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambridge-Major-and-AAIPharma-appoint-CFO-of-merged-company_57069.html
December 3, 2013
Merck KGaA eyes pharma acquisitions in the US Merck KGaA (Darmstadt, Germany) is looking to strengthen its presence in the prescription pharmaceuticals market in the United States and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-3-December-2013_57045.html
December 2, 2013
KKR, a leading global investment firm, says it will acquire a minority stake in Gland Pharma (Hyderabad, India), a leading Indian pure-play generic injectables pharmaceutical products...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/KKR-buys-stake-in-Indian-firm-Gland-Pharma-for-$200-million_57016.html
December 2, 2013
Glenmark Pharmaceuticals (Mumbai, India) says it has appointed Philip Gioia as president/North America and global active pharmaceutical ingredients (APIs). Gioia will be based at...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Glenmark-appoints-head-of-APIs-and-North-America-operations_57015.html
November 26, 2013
Merck KGaA (Darmstadt, Germany) is looking to strengthen its presence in the prescription pharmaceuticals market in the United States and is open to more collaborations and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-KGaA-eyes-pharma-acquisitions-in-the-US-strengthens-ties-with-Israeli-firms_56959.html
November 26, 2013
Johnson Matthey’s fine chemicals division reports rise in sales The fine chemicals division of Johnson Matthey (London), which comprises the company's active pharmaceutical...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-26-November-2013_56955.html
November 21, 2013
Johnson Matthey (London) reported £174.3 million ($281.1 million) in profit for its fiscal first half ended 30 September 2013, an increase of about 22% on the same period the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Johnson-Matthey-reports-22-percent-increase-in-first-half-profits_56849.html
November 19, 2013
DSM and JLL Partners (New York), a middle-market private equity firm, will create a new company, which will be a leading, global contract development and manufacturing organization...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSM-and-JLL-form-$2-billion-pharma-services-firm-by-merging-DSM-Pharmaceutical-Products-with-Patheon_56770.html
November 19, 2013
DSM and JLL form $2-billion pharma services firm by merging DSM Pharmaceutical Products with Patheon DSM and JLL Partners (New York), a middle-market private equity firm, will create a...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-19-November-2013_56774.html
November 14, 2013
Sorrento Therapeutics (San Diego), a publicly traded, development-stage biopharmaceutical company, says it has entered into a definitive agreement to acquire Concortis Biosystems (San...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Sorrento-to-acquire-antibody-drug-conjugation-technology_56696.html
November 14, 2013
About 30 workers who had occupied the manufacturing site of fine chemical company Calaire Chimie at Calais, France, for about three weeks, left the premises today after a court at...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Restructuring-to-go-ahead-at-fine-chemical-plant-in-France-after-court-evicts-protesting-workers_56702.html
November 13, 2013
NorthEdge Capital (Manchester, UK), a private equity firm focused on investing in businesses in the North of England, has acquired Fine Industries (Seal Sands, UK), a manufacturer of...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/NorthEdge-Capital-acquires-UK-firm-Fine-Industries_56662.html
November 12, 2013
CPhI 2013: Bullish mood at Frankfurt CPhI, the largest annual trade fair for the global pharmaceutical and pharma ingredients industry and held recently at Frankfurt, attracted about...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-12-November-2013_56636.html
November 11, 2013
Pharmaceuticals major Novartis (Basel) today announced a definitive agreement to divest its blood transfusion diagnostics unit, headquartered in Emeryville, CA, to Grifols (Barcelona)...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Novartis-to-divest-blood-transfusion-diagnostics-unit-to-Grifols-may-sell-animal-health-and-OTC-units_56610.html
Pages: « Previous  1 2 3 4 5 6 [7] 8 9 10 11 12 13 14 15 16 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa